ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy

Yosra Messai1, Muhammad Zaeem Noman1, Meriem Hasmim1

  • 1INSERM U753, Villejuif, France.

Cancer Research
|October 10, 2014
PubMed

Insights

Hypoxia-inducible factor 2-alpha (HIF2α) promotes clear cell renal cell carcinoma (RCC) survival by upregulating inositol 1,4,5-trisphosphate receptor type 1 (ITPR1), hindering natural killer cell activity. Targeting this axis enhances anti-tumor immunity.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Clear cell renal cell carcinoma (RCC) often involves von Hippel-Lindau (VHL) gene inactivation, increasing hypoxia-inducible factors (HIFs).
  • The role of HIF2α in modulating natural killer (NK) cell-mediated cytotoxicity in RCC remains largely unexplored.

Purpose of the Study:

  • To investigate the role of HIF2α in regulating RCC susceptibility to NK cell-mediated killing.
  • To identify novel molecular targets within the HIF2α pathway that influence RCC immune evasion.

Main Methods:

  • Utilized VHL-mutated (786-0) and VHL-corrected (WT7) RCC cell lines to assess NK cell lysis.
  • Employed gene expression profiling and chromatin immunoprecipitation assays to identify HIF2α targets.
  • Investigated the impact of ITPR1 modulation on autophagy and granzyme B activity.
  • Evaluated in vivo tumor regression following ITPR1 targeting.

Main Results:

  • VHL-mutated RCC cells exhibited resistance to NK cell lysis, dependent on HIF2α stabilization.
  • Identified inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) as a direct HIF2α target, with its overexpression contributing to NK resistance.
  • Targeting ITPR1 or Beclin-1 modulated autophagy and enhanced granzyme B activity in target cells.
  • In vivo targeting of ITPR1 significantly promoted NK-mediated tumor regression.

Conclusions:

  • HIF2α promotes RCC cell survival by upregulating ITPR1, which mediates resistance to NK cell killing via autophagy regulation.
  • The HIF2α/ITPR1 axis represents a novel pathway linking tumor hypoxia, immune evasion, and survival in RCC.
  • Targeting the HIF2α/ITPR1 pathway holds therapeutic potential for enhancing anti-tumor immunity in RCC.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.1K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
8.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
7.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K